标题
Targeting mutant p53 in cancer: a long road to precision therapy
作者
关键词
-
出版物
FEBS Journal
Volume 284, Issue 6, Pages 837-850
出版商
Wiley
发表日期
2016-11-03
DOI
10.1111/febs.13948
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- Mitochondria and Cancer
- (2016) Sejal Vyas et al. CELL
- Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer
- (2016) Dawid Walerych et al. NATURE CELL BIOLOGY
- Mutant p53 inhibits miRNA biogenesis by interfering with the microprocessor complex
- (2016) F Garibaldi et al. ONCOGENE
- The Dual Roles of NRF2 in Cancer
- (2016) Silvia Menegon et al. TRENDS IN MOLECULAR MEDICINE
- Interaction of p53 with prolyl isomerases: Healthy and unhealthy relationships
- (2015) Fiamma Mantovani et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- YAP enhances the pro‐proliferative transcriptional activity of mutant p53 proteins
- (2015) Silvia Di Agostino et al. EMBO REPORTS
- The Hippo transducer TAZ promotes epithelial to mesenchymal transition and cancer stem cell maintenance in oral cancer
- (2015) Zhongwu Li et al. Molecular Oncology
- Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment
- (2015) E. M. Alexandrova et al. NATURE
- Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth
- (2015) Jiajun Zhu et al. NATURE
- AMPK modulates Hippo pathway activity to regulate energy homeostasis
- (2015) Wenqi Wang et al. NATURE CELL BIOLOGY
- Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer
- (2015) Shuo Wei et al. NATURE MEDICINE
- Proteome-wide analysis of mutant p53 targets in breast cancer identifies new levels of gain-of-function that influence PARP, PCNA, and MCM4
- (2015) Alla Polotskaia et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mutant p53: One, No One, and One Hundred Thousand
- (2015) Dawid Walerych et al. Frontiers in Oncology
- Targeting Oncogenic Mutant p53 for Cancer Therapy
- (2015) Alejandro Parrales et al. Frontiers in Oncology
- Mutant p53 uses p63 as a molecular chaperone to alter gene expression and induce a pro-invasive secretome
- (2015) Paul M. Neilsen et al. Oncotarget
- Mutant p53 Drives Pancreatic Cancer Metastasis through Cell-Autonomous PDGF Receptor β Signaling
- (2014) Susann Weissmueller et al. CELL
- Mutant p53 reactivation by small molecules makes its way to the clinic
- (2014) Vladimir J.N. Bykov et al. FEBS LETTERS
- PML tumour suppression and beyond: Therapeutic implications
- (2014) Cristina Gamell et al. FEBS LETTERS
- Mutant TP53 Posttranslational Modifications: Challenges and Opportunities
- (2014) Thuy-Ai Nguyen et al. HUMAN MUTATION
- Gain-of-Function Mutant p53 Promotes Cell Growth and Cancer Cell Metabolism via Inhibition of AMPK Activation
- (2014) Ge Zhou et al. MOLECULAR CELL
- Mutant p53 Reprograms TNF Signaling in Cancer Cells through Interaction with the Tumor Suppressor DAB2IP
- (2014) Giulio Di Minin et al. MOLECULAR CELL
- Proteogenomic characterization of human colon and rectal cancer
- (2014) Bing Zhang et al. NATURE
- Metabolic control of YAP and TAZ by the mevalonate pathway
- (2014) Giovanni Sorrentino et al. NATURE CELL BIOLOGY
- A mutant p53/let-7i-axis-regulated gene network drives cell migration, invasion and metastasis
- (2014) M Subramanian et al. ONCOGENE
- Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients
- (2013) F. Ganci et al. ANNALS OF ONCOLOGY
- Mutant p53 Prolongs NF-κB Activation and Promotes Chronic Inflammation and Inflammation-Associated Colorectal Cancer
- (2013) Tomer Cooks et al. CANCER CELL
- Wild-type and mutant p53 mediate cisplatin resistance through interaction and inhibition of active caspase-9
- (2013) Jacqueline L.Y. Chee et al. CELL CYCLE
- Molecular Pathways: Current Role and Future Directions of the Retinoic Acid Pathway in Cancer Prevention and Treatment
- (2013) R. M. Connolly et al. CLINICAL CANCER RESEARCH
- Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast
- (2013) Alessandra Rustighi et al. EMBO Molecular Medicine
- Mutant p53 Regulates Dicer through p63-dependent and -independent Mechanisms to Promote an Invasive Phenotype
- (2013) Patricia A. J. Muller et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mutational landscape and significance across 12 major cancer types
- (2013) Cyriac Kandoth et al. NATURE
- Increased Oxidative Metabolism in the Li–Fraumeni Syndrome
- (2013) Ping-Yuan Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Disarming mutant p53 oncogenic function
- (2013) Javier E. Girardini et al. PHARMACOLOGICAL RESEARCH
- Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility
- (2013) Z. Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Mitochondrial disulfide relay mediates translocation of p53 and partitions its subcellular activity
- (2013) J. Zhuang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumour-associated mutant p53 drives the Warburg effect
- (2013) Cen Zhang et al. Nature Communications
- The rebel angel: mutant p53 as the driving oncogene in breast cancer
- (2012) D. Walerych et al. CARCINOGENESIS
- Mutant p53 Disrupts Mammary Tissue Architecture via the Mevalonate Pathway
- (2012) William A. Freed-Pastor et al. CELL
- Mutant p53 oncogenic functions are sustained by Plk2 kinase through an autoregulatory feedback loop
- (2012) Fabio Valenti et al. CELL CYCLE
- Dietary downregulation of mutant p53 levels via glucose restriction
- (2012) Olga Catalina Rodriguez et al. CELL CYCLE
- Mutant p53R273Hattenuates the expression of phase 2 detoxifying enzymes and promotes the survival of cells with high levels of reactive oxygen species
- (2012) Eyal Kalo et al. JOURNAL OF CELL SCIENCE
- Targeting p53 in Vivo: A First-in-Human Study With p53-Targeting Compound APR-246 in Refractory Hematologic Malignancies and Prostate Cancer
- (2012) Sören Lehmann et al. JOURNAL OF CLINICAL ONCOLOGY
- The microcosmos of cancer
- (2012) Amaia Lujambio et al. NATURE
- p53 mutations in cancer
- (2012) Patricia A. J. Muller et al. NATURE CELL BIOLOGY
- Mutant p53 enhances MET trafficking and signalling to drive cell scattering and invasion
- (2012) P A J Muller et al. ONCOGENE
- Mutant p53 drives invasion in breast tumors through up-regulation of miR-155
- (2012) P M Neilsen et al. ONCOGENE
- Investigating Metformin for Cancer Prevention and Treatment: The End of the Beginning
- (2012) Michael N. Pollak Cancer Discovery
- Wild-type and mutant p53 proteins interact with mitochondrial caspase-3
- (2011) Amanda K. Frank et al. CANCER BIOLOGY & THERAPY
- A Pin1/Mutant p53 Axis Promotes Aggressiveness in Breast Cancer
- (2011) Javier E. Girardini et al. CANCER CELL
- Multiple Stress Signals Activate Mutant p53 In Vivo
- (2011) Y.-A. Suh et al. CANCER RESEARCH
- Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration
- (2011) W.Andrew Yeudall et al. CARCINOGENESIS
- Mutant p53 protein localized in the cytoplasm inhibits autophagy
- (2011) Eugenia Morselli et al. CELL CYCLE
- Metformin, diet and breast cancer: An avenue for chemoprevention
- (2011) Paola Muti et al. CELL CYCLE
- MicroRNA-128-2 targets the transcriptional repressor E2F5 enhancing mutant p53 gain of function
- (2011) S Donzelli et al. CELL DEATH AND DIFFERENTIATION
- SAHA shows preferential cytotoxicity in mutant p53 cancer cells by destabilizing mutant p53 through inhibition of the HDAC6-Hsp90 chaperone axis
- (2011) D Li et al. CELL DEATH AND DIFFERENTIATION
- Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant p53 in Human Cancer Cells
- (2011) D. Li et al. MOLECULAR CANCER RESEARCH
- Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53
- (2010) Perry Stambolsky et al. CANCER CELL
- Promyelocytic Leukemia Protein is Required for Gain of Function by Mutant p53
- (2009) S. Haupt et al. CANCER RESEARCH
- Mutant p53 Drives Invasion by Promoting Integrin Recycling
- (2009) Patricia A.J. Muller et al. CELL
- A Mutant-p53/Smad Complex Opposes p63 to Empower TGFβ-Induced Metastasis
- (2009) Maddalena Adorno et al. CELL
- The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs
- (2009) Michele Trabucchi et al. NATURE
- The execution of the transcriptional axis mutant p53, E2F1 and ID4 promotes tumor neo-angiogenesis
- (2009) Giulia Fontemaggi et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- A common gain of function of p53 cancer mutants in inducing genetic instability
- (2009) D P Liu et al. ONCOGENE
- The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss
- (2008) T. Terzian et al. GENES & DEVELOPMENT
- Dissecting the role of p53 phosphorylation in homologous recombination provides new clues for gain-of-function mutants
- (2008) A. Restle et al. NUCLEIC ACIDS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started